Research Wilmot Discovery Improves Use of Umbilical Cord Blood as Cancer Therapy By Leslie Orr Jan. 3, 2017 A clinician/scientist, who studies ways to make cord-blood transplants for leukemia and lymphoma patients safer and more effective, recently reported a new finding in the journal, Blood. An ...
Research Immunotherapy Study Involving Wilmot Makes Headlines at National Meeting By Leslie Orr Dec. 6, 2016 Wilmot Cancer Institute physicians and patients were part of a groundbreaking immunotherapy study that’s taking center stage this week in the world of cancer research.
Patient Care Wilmot Cancer Institute celebrates 3,000th blood and marrow transplant By Lydia Fernandez Aug. 27, 2016 The Blood and Marrow Transplant (BMT) Program at UR Medicine’s Wilmot Cancer Institute recently performed its 3,000th transplant. The program, which opened in 1989, treats both adults and children ...
Patient Care Wilmot announces 2016 Wilmot Warrior Walk honorees By Ruth Harper-Rhode Aug. 11, 2016 UR Medicine’s Wilmot Cancer Institute will honor 28 cancer survivors and caregivers at the fourth annual Wilmot Warrior Walk taking place Sunday, Sept. 11, at the Highland Park Bowl in Rochester. ...
Patient Care Wilmot Patient Grateful for Clinical Study, Recovering at Home By Leslie Orr Apr. 12, 2016 Ed Foster, the first patient to participate in a national clinical trial of a new immunotherapy for lymphoma at the Wilmot Cancer Institute, is healthy enough to be home in Elmira.
Research Wilmot Embarks on “first real big test” of Immunotherapy for Lymphoma By Leslie Orr Mar. 14, 2016 UR Medicine’s Wilmot Cancer Institute is part of a national clinical trial for an innovative new therapy that involves engineering a patient’s own immune cells to attack cancer, in this case lymphoma.
Research Wilmot Researchers Define Unique Group of High-Risk Lymphoma Patients By Leslie Orr Jun. 29, 2015 The goal for many cancer patients is to reach the five-year, disease-free mark, but new research from UR Medicine’s Wilmot Cancer Institute suggests that two years might be a more practical survival ...
Patient Care Wilmot Cancer Institute’s Blood and Marrow Transplant Program Receives Prestigious Accreditation By Ruth Harper-Rhode May. 4, 2015 The Blood and Marrow Transplant (BMT) Program at UR Medicine’s Wilmot Cancer Institute was recognized for its high level of care and detailed quality management processes with a three-year ...
Research Low Vitamin D Linked to Worse Prognosis in Type of Non-Hodgkin Lymphoma By Leslie Orr Mar. 30, 2015 A new study found that people with lower vitamin D levels prior to treatment for follicular lymphoma succumb to the disease or face relapse earlier than patients with sufficient vitamin D levels in ...
Research Wilmot Clinical Trial Tests Antibiotic as Lymphoma Treatment By URochester Medicine Communications Jul. 24, 2014 Military troops take doxycycline to prevent infections and malaria, and teenagers use it to treat acne. Wilmot Cancer Institute scientists are also testing it for the treatment of lymphoma.
